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1. Introduction
Complementary alternative medicine (CAM) has been widely used for a long time for the
treatment of multiple diseases, despite the great advances in allopathic medicine. It is esti‐
mated that about 80% of the world population use some form of CAM.
CAM encompasses empirical knowledge and medical practice in which use is made of herb‐
al medicinal plants, animals, minerals, manual therapy and exercise, alone or in conjunction
for the treatment of diseases. In the early 1980's there emerged a strong interest in their
study that has significantly influenced the pharmaceutical industry in developing technolo‐
gies to identify new chemical entities and structures that are used for the synthesis of drugs.
It has been shown that natural products play an important role in the discovery of com‐
pounds for drug development to treat multiple diseases.
Also, is important to recognize that use plants and their products have provided proven
benefits to humanity, which falls into four areas: (i) food, (ii) essences and flavoring agents,
(iii) perfumes and cosmetics, and (iv) biological and pharmaceutical agents [1]. Within the
pharmaceutical area, the current outlook for natural products in drug discovery takes a cen‐
tral role, since at the beginning of this new millennium, only about 10% of 350,000 known
species have been investigated from a phytochemical or pharmacology point of view [1].
© 2013 Ávila et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
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A great examples of molecules that have hit the market as drugs by isolation from natu‐
ral products metabolites are: taxol (1), an antitumor agent isolated from Taxus species [2]
and  camptothecin  (2),  isolated  from  the  Chinese  plant  Camptotheca  acuminate  Decne
(Nyssaceae), used to treat ovarian, breast and colorectal cancer, another example is ephe‐
drine (3), which is isolated from the plant Ephedra sinica3 and is used as a flu remedy. In
drug  discovery,  researchers  around  the  world  use  plants  as  an  essential  route  in  the
search for new drugs leaders.  One of  the main objectives of  the research laboratories  is
the  preliminary  meeting  with  isolated  bioactive  natural  products,  and  its  uses  as  anti‐
cancer, antiviral, antimalarial, antifungal and anti-inflammatory [3]. The search for active
compounds in plants is an essential way for the development of new drugs, a process in
which there is now more advanced and specific methodologies for the analysis of biolog‐
ical activities in particular.
Documentary research from 1981 to 2006 showed that natural products have been a source
of 5.7% of drugs produced in those years. The derivatives of natural products are most of
the times, chemical molecules synthetized from natural products and contributed to the
27.6% of the total of the new molecule.
2. Characterization of Geranium genus
Geranium genus is taxonomically classified within the family Geraniaceae Juss, which in‐
cludes five to eleven genuses, and in total near to 750 species. The genus best known are
Geranium genus, as wild plants (Figure 1) and Pelargonium genus, as garden plants. The
names of these genuses usually cause confusion because “geranium”, is the common name
for certain species of Pelargonium.
The names come from Greek and refer to the form that its fruits acquire, likes beaks. Thus,
the word "Geranium" comes from “geranos" meaning crane, and "Pelargonium" derived
from "Pelargos" meaning stork [4].
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Figure 1. Geranium genus.
Subgenus Section Number of Species
Erodioidea
Erodioidea 3
Aculeolata 1
Subacaulia 15
Brasiliensia 3
Geranium
Geranium 339
Dissecta 4
Tuberosa 19
Neurophyllodes 6
Paramensia 2
Azorelloida 1
Polyantha 7
Robertium
Trilopha 5
Divaricata 2
Batrachioidea 4
Ungiculata 5
Lucida 1
Ruberta 4
Anemonifolia 2
Table 1. Geranium genus clasification
Within the classification of Geranium genus are accepted 423 species, distributed in three
subgenuses: Erodioidea, Geranium and Robertium. The following table (Table 1) shows the
distribution of this classification.
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Currently, in Hidalgo state, in Central Mexico, are classified 8 different species [5] and any‐
one has chemical or pharmacological studies.
2.1. Biological activities and compounds isolated from Geranium species
Some species of Geranium  that have been studied has shown biological activity like:  hy‐
potensive,  mild  astringents,  diuretics,  hepatoprotection,  antioxidants,  anti-inflammatory
and antiviral. Geranium species also are used as a remedy for tonsillitis, cough, whooping
cough, urticarial,  dysentery, kidney pain and gastrointestinal disorders [6-8].  It  is proba‐
bly that the species of this genus that growing in the State of Hidalgo possess a similar
biological  activities  and metabolites.  All  phytochemicals  studies described for these spe‐
cies,  indicates the presence of polyphenolic compounds called tannins,  which have been
considered  as  water-soluble  compounds  of  molecular  weight  between  500  and  30,000
g/mol with special properties such as the ability to precipitate alkaloids, gelatin and oth‐
er proteins [9].  Nowadays tannins are well  known because of its  antioxidant properties.
Tannin-protein  complexes  in  the  gastrointestinal  tract  provide  persistent  antioxidant  ac‐
tivity.
One of the major components in Geranium species isgeraniin (4) [10] described by its discov‐
erer as a crystallizable tannin. This substance first isolated from Geranium thunbergi Sieg. Et
Zucc. by T. Okuda in 1976, has been evaluated showing an antihypertensive activity, gera‐
niin inhibits the angiotensin converting enzyme [11,12] and reverse transcriptase of tumoral
viruses RNA [13], inhibit HSV-1 and HSV-2 multiplication at different magnitudes of poten‐
cy and also is an excellent antioxidant [14]. The corilagin (5) [15] is a derivative of geraniin,
which has presented antimicrobial activity among other activities [16].
2.2. Different species of geraniums and its relevant compounds
The specie Geranium macrorizum presented a significant hypotensive activity in anesthe‐
tized cats [17], plus antioxidant activity. Of this specie germacrone (6) was isolated which is
considered a precursor of pheromones.
Geranium robertianum L.  well-known specie  and one  of  the  most  variable  in  Britain  has
been used in conditions where increased diuresis is  required, such as cystitis,  urethritis,
pyelonephritis,  gout,  hypertension  and  edema.  Nowadays  the  phytochemistry  of  this
geranium is  relatively  well  known and its  most  studied active  compounds are  tannins,
volatile  oils,  flavonoids  and  polyphenols  (hyperoside,  ellagic  acid,  isoquercitrin,  querci‐
trine,  kaempferols,  caftaric  acid,  rutoside).Also  infusions  and  decoctions  prepared  from
leaves  of  this  geranium:  Robert  herb  or  red  Robin,  are  described  as  anti-hyperglycae‐
miant and commonly used in Portuguese herbal medicine [18]. In other hand G. robertia‐
num  extract  treatment  increased  the  efficiency  of  coupling  between  oxidative  and
phosphorylative systems, since RCR was considerably higher in GK rats consuming this
plant extract [19].
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Recently the extracts of G. sylvaticum were studied [20] for antioxidant potential and all test‐
ed extracts had strong antioxidant activity and will be subject for further investigations.
From flowers of Geranium sylvaticum was isolated 3-O-(6-O-acetyl-∙-D-glucopyranoside)-5-
O-∙-D-glucopyranoside of malvidin (7) [21].Geranium sanguineum L. showed significant in‐
hibitory activity of influenza virus and herpes simplex (8). The methanolic extract of
Geranium pratense inhibited the action of the amylase enzyme in mouse plasma, isolated for
first time the 3-O-(2-O-galloyl) -∙-D-glucopyranoside myricetin(9) [22].
Geranium niveum,  widely used by the Tarahumara Indians of Mexico.  Is  a specie rich in
proanthocyanidins and other phenolics [23].  Previous in vitro assays have demonstrated
that proanthocyanidins exhibited antiinflammatory, antiviral,  antibacterial,  enzyme-inhib‐
iting, antioxidant, and radical-scavenging properties, the roots 25 of this species were iso‐
lated new proanthocyanidins named as  geraniins  A (9)  and B (9a),  latterlyin 2001 were
found geraniins C (10) and D (10a) [24]. A recently study showed that geraniin A has an‐
tioxidant activity [25].
Geranium pusillum, commonly known as Small-flowered Cranesbill or (in North America)
small Geranium, contains1-O-galloyl-3,6-hexahidroxibifenil-D-galactopyranoside (11) (pusi‐
lagin) a polyphenolic compound extracted from aerial parts [26]. The aqueous ethanolic ex‐
tract of Geranium wallichianum showed antibacterial activity against Staphylococcus aureus
[27] and the study of the chemical constituents of the whole plant has resulted in the isola‐
tion and characterization of six compounds. These six compounds were identified as ursolic
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acid, β-sitosterol, stigmasterol, β-sitosterol galactoside, herniarin, and 2,4,6-trihydroxyethyl‐
benzoate which were isolated for the first time from Geranium wallichianum [28].
Geranium caespitosum produces neohesperidoside (12) able to potentiate 10 to 100 times the
action of drugs such as ciprofloxacin, norfloxacin, berberine and rhein, against bacterias
such as S. aureus, NorA S. aureus, B. and B. megaterium subtilis [29]. Besides, Geranium caroli‐
nianum L., isa commonly used traditional Chinese medicine (TCM) with the efficacy of elim‐
inating wind-damp and treating diarrhea. It is clinically used to treat the arthralgia due to
wind-dampness, anaesthetization and muscular constriction. It has been reports that Gerani‐
um carolinianum L. as well of most of the congeneric plants contain significant amounts of
tannins, flavonoids, organic acids, and volatile oils [30].Also, has shown that roots contain a
substance that is extracted with water and can be a biological mechanism to control bacteria
(Ralstonia solanacearum) which attacks potatoes [31].
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From Geranium pyrenaicum, which showed antileishmanial activity [32],a new glycosylate
flavonoid: 3-O-(2 ", 3"-di-O-galloyl)- ∙-D-glucopyranoside of kaempferol (13) was isolated,
and anuncommon quercetin derivative: 3-O-(2 ", 3"-di-O-galloyl) - ∙-D-glucopyranoside of
quercetin (13a) too. In Geranium mexicanum an antiprotozoal activity was assayed from its
roots, where the most active compound founded was the flavan-3-ol-(-)-epicatechin (14),
showing moderate activity (+)-catechin (14a), tyramine (15) and 3-O-β-D-glucopyranoside of
β-sitosterol [33].
Geranium bellum Rose is a perennial plant with long roots, found in the grassy meadows border‐
ing pine/oak forests in the mountains of Hidalgo State, Mexico, where it has the popular name
“pata de león” and has been used as a traditional remedy for treatment of fevers, pain, and gas‐
trointestinal  disorders.  Radical  scavenging  assay-guided  fractionation  of  the  antioxidant
EtOAc and MeOH extracts from the aerial parts of Geranium bellum resulted in the isolation of b-
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sitosterol  3-O-b-D-glucopiranoside,  quercetin  3-O-a-L-(2”-O-acetyl)arabinofuranoside  (16),
quercetin 3-O-a-L-arabinofuranoside, quercetin, methyl gallate, gallic acid, methyl brevifolin
carboxylate (17), and dehydrochebulic acid trimethyl ester (18). Compounds 2, 7 and 8 are iso‐
lated for the first time from Geranium genus [34]. Antioxidant activity of these extracts (both ini‐
tial fractions and pure compounds), was tested by measuring their capacity to scavenge 2,2’-
azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) radicals, an assay widely used for
screening of antioxidant activity of natural products [15].
Constituents from the aerial parts of Geranium potentillaefoium founded in certain studies
were geraniin, corilagin, gallic acid, methyl gallate, methyl brevifolincarboxylate, quercetin,
quercetin 3-O-β-Dglucopyranoside, quercetin 3-O-β-D- [6”-O-galloyl)glucopyranoside,
kaempferol, β-sitosterol 3-O-β-D-glucopyranoside and β-sitosterol [35].
3. Study of Geranium schiedeanum
Geranium schiedeanum (Gs) (Figure 2), species that grows in Central Mexico, has been used as
an antipyretic, anti-inflamatory and antiseptic. The use of other geranium species also has
been reported a hypoglycemic, antihypertensive and cholesterol-lowering effect. However,
scientific evidence does not exist in any literature to corroborate these targets or any other.
In the present study the effect of Gs were studied in reference to postnecrotic liver damage
induced by thioacetamide (TA).
Figure 2. Geranium schiedeanum [5]
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3.1. Plant material
Specimen of Geranium schiedeanum  was collected at Epazoyucan Municipality, in Hidalgo
State, México, during June 2009. A voucher specimen (J. A. Gayosoo-de-Lucio) is preserved
at the Herbarium of Biological Research Centre, Autonomous University of Hidalgo, Pachu‐
ca, Hidalgo, Mexico where Professor Manuel González Ledesma identified the plant mate‐
rial.
3.2. Extraction and purification
Air-dried aerial parts (1 kg) were extracted acetone-H2O 7:3 (20 L) by maceration for 7 days.
Vacuum evaporation of dissolvent give a 5 L residue Filtration give a fatty solid residue
(12g) and complete evaporation of water give the acetone-water extract (115 g).
Lots of 3 g of acetone-water extract were purified on a Sephadex LH-20 (25 g) column us‐
ing H2O, H2O-MeOH (9:1, 4:1, 7:3, 3:2, 1:1, 2:3, 3:7, 1:4, 1:9 ) and MeOH, as eluents. Frac‐
tions of 300 mL of each polarity were collected and marked “A–K”. They were evaporated
and analyzed by TLC and NMR. Fractions “B” gave 75 mg, and were purified over silica
gel (10 g), using CHCl3, CHCl3-AcOEt(9:1, 4:1, 7:3, 3:2, 1:1, 2:3, 3:7, 1:4, 1:9 ) and AcOEt (10
mL of each polarity), as eluents and collecting fractions of 7 mL, fractions 13-16 give I 25
mg. Fractions “C” and “D” gave 56 mg,  and were purified over silica gel  (10 g),  using
CHCl3-MeOH (50:7.0, 48:7, 45:7, 40:7, 35:7 and 30:7, 40 mL of each), as eluents and collect‐
ing fractions of 7 mL, fractions 33-66 give II 2 mg, (these procedure was repeated ten times
to obtain 18 mg of compound), Fractions “F-I” gave 1.8 g, a portion of 500 mg were puri‐
fied over silica gel C-18 (5 g) using H2O, H2O-MeOH (9:1, 4:1, 7:3, 3:2, 1:1, 2:3, 3:7, 1:4, 1:9 )
and MeOH (20 mL of each polarity), fractions of 10 mL were collected fractions 2-4 gave
325 mg of  III,  fraction “K” gave 90 mg were added 5  mL of  (40°C)  pyridine and were
placed a room temperature for 72 h, filtrated of mixture give a yellow needles 60 mg of IV
(Figure 3).
Figure 3. Extract fractions scheme.
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3.3. Animals and treatment
Male adult Wistar rats 2 months old (200–220g) were obtained from UAEH Bioterio, and
acclimated to our animal room for two weeks before use. Throughout these two weeks rats
were supplied with food and water ad libitum, exposed to a 12 h light-dark cycle and giv‐
en intraperitoneally a single necrogenic dose of thioacetamide (6.6 nmol/Kg body weights)
freshly dissolved in 0.9% NaCl. The dose of thioacetamide was chosen as the highest dose
with survival above 90% [36,37]. Wistar rats were intragastric pre-treated or not with a sin‐
gle dose of Gs extract (300 mg/kg) during 4 days, the fourth day of pretreatment were in‐
traperitoneally injected with a single dose of TA (6.6 mmol/Kg). Samples of blood and liver
were obtained from rats at 0, 24, 48,72 and 96 h following TA intoxication. Untreated ani‐
mals received 0.5 ml of 0.9% NaCl. Experiments were performed on two different groups:
rats  treated with  a  single  dose  of  thioacetamide (TA)  and rats  pre-treated with  Gs and
treated with a single dose of thioacetamide (Gs + TA). Each experiment was performed in
duplicate  from four different  animals  and followed the international  criteria  for  the use
and care of experimental animals outlined in The Guiding Principles in the use of Animals in
Toxicology adopted by the Society of Toxicology in 1989.
3.4. Processing of samples
In order to clarify the sequential changes during the different stages of liver injury and the
post-necrotic regenerative response, samples were obtained from control and at 24 and 48 h
of TA intoxication in both Gs pre-treated or non pre-treated animals. Rats were sacrificed by
cervical dislocation and samples of liver were obtained and processed as previously descri‐
bed. Blood was collected from hearts and kept at 4 °C for 24 h, centrifuged at 3000 rpm for
15 min, and serum was obtained as the supernatant.
3.5. Determination of AST
Enzymatic determination were carried out in serum in optimal conditions of temperature
and substrate and cofactor concentrations. Aspartate aminotransferase (AST) activity were
determined in serum. AST (EC 2.6.2.1) and was assayed following the method of Rej and
Horder [38].
The activity of this enzyme was determined spectrophotometrically, by measuring the de‐
crease in absorbance at 340 nm at 37 ° C, produced by the oxidation of NADH to NAD+ in
the coupled reaction of reduction of oxaloacetate to malate, catalyzed by malate dehydro‐
genase, according to the following process:
3.6. General
IR spectra measured in MeOH on a Perkin Elmer 2000 FT-IR spectrophotometer. Optical
rotations were determined in MeOH on a Perkin Elmer 341 polarimeter. NMR measure‐
ments performed at 400 MHz for 1H and 100 MHz for 13C on a VARIAN 400 spectrom‐
eter  from  CDCl3,  CD3OH,  DMSO-d6  solutions.  Column  chromatography  (CC)  was
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carried  out  on  Merck  silica  gel  60  (Aldrich,  230-400  mesh ASTM) and sephadex  LH-20
Sigma Aldrich.
3.7. Statistical analysis
The results were calculated as the means ± SD of four experimental observations in dupli‐
cate (four animals). Differences between groups were analyzed by an ANOVA following
Snedecor F (α = 0.05). Students’ test was performed for statistical evaluation as follows: (a)
all values against their control; b) differences between two groups Gs + TA versus TA.
3.8. Results
3.8.1. Active compounds of Geranium schiedeanum
One kg of the aerial part of G. schiedeanum was extracted by maceration for 7 days with 20 L
acetone-water (7:3), concentrated under reduced pressure to a volume of 3 L, which was ex‐
tracted with CHCl3 yielding 12.75 g of CHCl3 phase and 125 g of aqueous phase. The phyto‐
chemical study of Geranium schiedeanum led to the isolation of hydrolysable tannins (I) gallic
acid, (III) acetonylgeraniin and (IV) ellagic acid and to a lesser proportion of kaempferol gly‐
cosideflavonoid (II) (Figure 4 and 5). Is relevant to notice that is the first time discloses the
compound II in the Geranium genus and further that the yield of compound III in the crude
extract was 40%.
Figure 4. Compound (II) 3-O-α-L-arabinofuranoside-7-O-β-L-rhamnopyranoside de Kaempferol
Geranium Species as Antioxidants
http://dx.doi.org/10.5772/52002
123
Figure 5. HMBC experiment of compound II
3.8.2. Aspartate aminotransferase
The acute liver injury induced by a necrogenic dose of thioacetamide (TA), a potent hepato‐
toxic agent, is characterized by a severe perivenous necrosis [39]. The necrosis develops as a
consequence of the biotransformation of TA through the microsomal flavin-dependent mon‐
ooxygenase [40]. The reactive metabolites responsible for TA hepatotoxicity are the radicals
derived from thioacetamide-S-oxide and the reactive oxygen species derived as sub prod‐
ucts in the process of microsomal TA oxidation, both of which can depleted reduced gluta‐
thione leading to oxidative stress [41, 42].
Liver damage induced by xenobiotics is characterized by the release in serum of hepatic en‐
zymes due to necrosis of hepatocytes. AST is randomly distributed in the hepatic acinus,
and is the enzyme activity used as marker of necrosis. Our results showed that Gs extract
significantly reduced the level of liver injury. The levels of AST (Figure 6) were significantly
lower in the rats pretreated with Gs.
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Figure 6. Effect of Gs pre-treatment on aspartate aminotransferase activity in serum of rats intoxicated with one sub‐
lethal dose of thioacetamide. Samples were obtained at 0, 24, 48, 72 & 96 h following thioacetamide (TA). The results,
expressed as nmol per min per ml of serum, are the mean ± SD of four determinations in duplicate from four rats.
Differences against the respective control are expressed as (a) and differences due to Gs extract are expressed as (b)
p<0.05.
4. Conclusion
There is evidence that free radicals play a critical role in certain pathological conditions such
as some cancers, multiple sclerosis, inflammation, arthritis and arterosclerosis [43]. For this
reason, some research objectives directed toward the development or discovery of these
compounds catchers of these radicals.
A large number of plant species, like G. schiedeanum contain chemical compounds that ex‐
hibit the ability to trap free radicals. The ability to trap free radicals has been called antioxi‐
dant activity. The phytochemical study of Geranium shiedeanum led to the isolation of
hydrolysable tannins, well known as potent antioxidants: gallic acid, acetonylgeraniin and
ellagic acid and a lesser proportion of kaempferol glycoside flavonoid (3-O-α-L-arabinofura‐
noside-7-O-β-D-rhamnoside de Kaempferol), notably is the first time discloses these com‐
pounds in the genus. Further the yield of acetonyl geraniin in the crude extract was 40%.
Also, in the present study TA-induced hepatotoxicity was used to investigate the effect of
the pretreatment of G. schiedeanum on the events involved in liver regeneration. The results
obtained in the present study provide evidence that Gs, when administered intravenously
prior to TA, significantly reduce liver damage.
The pre-treatment with the crude extract in the model of thioacetamide-induced hepatotox‐
icity in rats, decreased and delayed liver injury by 66% at 24 h.
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The data obtained indicate that the crude Gs extract pre-treatment has hepatoprotective and
antioxidant effect in damage induced by TA. This result suggests that Gs extract may be
used as an alternative for reduction of liver damage. However further investigation on the
acute toxicity and on the mechanism of the hepatoprotective effect of the plant species needs
to be carried out.
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